Kelly Beasy compares the 4 cosmetic neurotoxins on the market that all contain the same active ingredient and are FDA approved to treat the same concerns.
Melanography, aesthetic medicine, skin cancer and more - tailored for nurses.
Focused clinical courses on a single topic. Under 10 hours, assessment included.
Short courses in skin cancer, geriatric care, and chronic disease - tailored for nurses.
4,000+ CPD hours across every major topic area. One flat annual fee, cancel anytime.
Kelly Beasy compares the 4 cosmetic neurotoxins on the market that all contain the same active ingredient and are FDA approved to treat the same concerns.
In this latest podcast, Kelly Beasy (KB Aesthetix) compares the quartet of cosmetic neurotoxins on the market that each contain the same active ingredient (BoNT-A) and are FDA approved to treat the same aesthetic concerns: Botox®, Dysport®, Letybo®, and Xeomin®). She also covers the various types of dermal filler and which type to use for which treatment.
For further information on this topic, you may be interested to learn more about HealthCert's Professional Diploma program in Aesthetic Medicine - online aesthetics training for GPs, with optional workshops.
In this episode of HealthCert’s GP Insights podcast, Paul Elmslie (CEO & Founder of HealthCert Education) talks with Kelly Beasy about the different neurotoxins available in the market. Kelly is a Nurse Practitioner and cosmetic medicine trainer at KB Aesthetix, with 20 years of nursing experience and 10+ years’ experience in the aesthetic industry. Learn more about KB Aesthetix.
Hear all this and much more in the full podcast above!
For further information on this topic, you may be interested to learn more about HealthCert's Professional Diploma program in Aesthetic Medicine - online aesthetics training for GPs, with optional workshops.
Listen to another podcast: Profhilo®: The new bio-remodelling injectable treatment